ORIC PHARMACEUTICALS INC's ticker is ORIC and the CUSIP is 68622P109. A total of 84 filers reported holding ORIC PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.28 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $805,291 | -28.7% | 133,106 | -8.6% | 0.00% | – |
| Q2 2023 | $1,129,476 | +58.2% | 145,551 | +16.2% | 0.00% | – |
| Q1 2023 | $713,851 | +269.7% | 125,237 | +282.1% | 0.00% | – |
| Q4 2022 | $193,074 | +103.2% | 32,780 | +11.1% | 0.00% | – |
| Q3 2022 | $95,000 | -14.4% | 29,518 | +18.8% | 0.00% | – |
| Q2 2022 | $111,000 | -31.5% | 24,857 | -18.1% | 0.00% | – |
| Q1 2022 | $162,000 | -85.9% | 30,341 | -61.0% | 0.00% | – |
| Q4 2021 | $1,145,000 | +322.5% | 77,863 | +500.1% | 0.00% | – |
| Q3 2021 | $271,000 | -22.8% | 12,974 | -34.5% | 0.00% | – |
| Q2 2021 | $351,000 | +39.3% | 19,814 | +92.4% | 0.00% | – |
| Q1 2021 | $252,000 | +183.1% | 10,299 | +288.2% | 0.00% | – |
| Q4 2020 | $89,000 | +117.1% | 2,653 | +60.7% | 0.00% | – |
| Q3 2020 | $41,000 | -90.9% | 1,651 | -87.6% | 0.00% | – |
| Q2 2020 | $451,000 | – | 13,360 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 602,272 | $2,698,000 | 8.92% |
| Column Group LLC | 3,568,181 | $15,985,000 | 3.40% |
| Euclidean Capital LLC | 747,550 | $3,349,000 | 2.85% |
| Invus Financial Advisors, LLC | 1,007,575 | $4,514,000 | 2.72% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 1,082,304 | $4,849,000 | 1.49% |
| Monaco Asset Management SAM | 364,741 | $1,634,000 | 0.71% |
| EcoR1 Capital, LLC | 3,418,068 | $15,313,000 | 0.53% |
| DAFNA Capital Management LLC | 415,926 | $1,863,000 | 0.51% |
| Boxer Capital, LLC | 1,054,000 | $4,722,000 | 0.30% |
| Casdin Capital, LLC | 601,515 | $2,695,000 | 0.23% |